Delivery Order SPE2DB22D3102-SPE2DB25FL2CY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,617.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Montelukast Sodium 10 mg, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger prime contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,366.73 to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 5 mg chewable tablets (90-count packaging). The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Montelukast Sodium 5 mg Chewable Tablets in quantities of 90s, with a ceiling value of $2,505.94 and a period of performance through May 2, 2025. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Montelukast 5mg tablets (90-unit quantity) with a ceiling value of $3,561.84. This delivery order was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- This federal contract award is for the delivery of SINGULAIR 4 MG GRANULES 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $1,552.56 and a performance period through March 28, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets in a quantity of 180 units, valued at $19,641.70. This delivery order is issued under a firm fixed-price contract type with no set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $1,659.27 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Fluticasone-Salmeterol 230-21 12GM, a combination asthma and chronic obstructive pulmonary disease maintenance medication. This delivery order represents a firm fixed price, non-set-aside contract with an ultimate completion date of June 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,979.42 delivery order to AmerisourceBergen Drug Corp for Fluticasone-Salmeterol 115-21 12GM pharmaceutical products on July 21, 2025. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. The products will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,711.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Fluticasone-Salmeterol 115-21 12GM pharmaceutical product. This is a non-set-aside competitive award with an ultimate completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,750.95 to AmerisourceBergen Drug Corp for Fluticasone-Salmeterol 45-21 12GM, a combination pharmaceutical product commonly used to treat asthma and chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was executed on May 8, 2025, with an ultimate completion date of May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2CYDelivery Order
This delivery order, awarded July 10, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 30-count packages of Montelukast Sodium 4 mg granules for a firm fixed price of $1,372.26. The contract is scheduled for completion by July 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order without special contracting provisions. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle supports the Defense Health Agency and other federal healthcare systems by supplying a comprehensive range of pharmaceutical products and medical supplies globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated sustained capability to fulfill federal medical procurement requirements through competitive awards, with this Montelukast order exemplifying the routine pharmaceutical deliveries executed under the broader strategic medical supply framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/10/25 |